v3.26.1
Condensed Statement of Changes in Shareholders' Deficit - USD ($)
Total
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Class A Ordinary Shares [Member]
Class A Ordinary Shares [Member]
Common Stock [Member]
Class B Ordinary Shares [Member]
Common Stock [Member]
OHB Pediatrics Ltd [Member]
OHB Pediatrics Ltd [Member]
Common Stock [Member]
OHB Pediatrics Ltd [Member]
Additional Paid-In Capital [Member]
OHB Pediatrics Ltd [Member]
Accumulated Deficit [Member]
OHB Pediatrics Ltd [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Beginning balance, shares at Sep. 15, 2024               0      
Beginning balance, amount at Sep. 15, 2024             $ 0 $ 0 $ 0 $ 0  
Issuance of Class B ordinary shares to Sponsor, shares               10,000      
Issuance of Class B ordinary shares to Sponsor, amount             0 $ 0 0 0  
Net income (loss)             (357,000) $ 0 0 (357,000)  
Issuance of shares, Shares               10,000      
Issuance of shares, Amount             $ 0 $ 0 0 0  
Ending balance, shares at Dec. 31, 2024             10,000 10,000     0
Ending balance, amount at Dec. 31, 2024             $ (357,000) $ 0 0 (357,000) $ 0
Net income (loss)             (2,958,000) $ 0 0 (2,958,000) $ 0
Ending balance, shares at Jun. 30, 2025               10,000     0
Ending balance, amount at Jun. 30, 2025             $ (3,315,000) $ 0 0 (3,315,000) $ 0
Beginning balance, shares at Dec. 31, 2024             10,000 10,000     0
Beginning balance, amount at Dec. 31, 2024             $ (357,000) $ 0 0 (357,000) $ 0
Issuance of Class B ordinary shares to Sponsor, shares             1,000,000 1,000,000      
Issuance of Class B ordinary shares to Sponsor, amount             $ (15,976,000) $ 0 (15,976,000) 0  
Net income (loss)             $ (15,650,000) $ 0 0 (15,650,000)  
Issuance of shares, Shares             1,000,000 1,000,000      
Issuance of shares, Amount             $ 15,976,000 $ 0 15,976,000 0  
Ending balance, shares at Dec. 31, 2025             1,010,000 1,010,000     0
Ending balance, amount at Dec. 31, 2025             $ (31,000) $ 0 15,976,000 (16,007,000) $ 0
Issuance of Class B ordinary shares to Sponsor, shares               61,302,500     32,500,000
Issuance of Class B ordinary shares to Sponsor, amount             0 $ 0 0 0 $ 31,890,000
Net income (loss)             (13,507,000) $ 0 0 (13,507,000) $ 0
Issuance of shares, Shares               61,302,500     32,500,000
Issuance of shares, Amount             $ 0 $ 0 0 0 $ (31,890,000)
Ending balance, shares at Jun. 30, 2026         275,000 1,323,529 62,312,500 62,312,500     32,500,000
Ending balance, amount at Jun. 30, 2026 $ (1,236,918) $ 0 $ (1,237,078)   $ 28 $ 132 $ (13,538,000) $ 0 15,976,000 (29,514,000) $ 31,890,000
Beginning balance, shares at Feb. 18, 2026         0 0          
Beginning balance, amount at Feb. 18, 2026 0 0 0   $ 0 $ 0          
Issuance of Class B ordinary shares to Sponsor, shares           1,323,529          
Issuance of Class B ordinary shares to Sponsor, amount 25,000 24,868 0     $ 132          
Net income (loss) (33,697) 0 (33,697)     $ 0          
Issuance of shares, Shares           1,323,529          
Issuance of shares, Amount (25,000) (24,868) 0     $ (132)          
Ending balance, shares at Feb. 25, 2026           1,323,529          
Ending balance, amount at Feb. 25, 2026 (8,697) 24,868 (33,697)     $ 132          
Beginning balance, shares at Feb. 18, 2026         0 0          
Beginning balance, amount at Feb. 18, 2026 0 0 0   $ 0 $ 0          
Issuance of Class B ordinary shares to Sponsor, shares         0 1,323,529          
Issuance of Class B ordinary shares to Sponsor, amount 25,000 24,868 0   $ 0 $ 132          
Net income (loss) (65,249) 0 (65,249)   $ 0 $ 0          
Issuance of shares, Shares         0 1,323,529          
Issuance of shares, Amount (25,000) (24,868) 0   $ 0 $ (132)          
Ending balance, shares at Mar. 31, 2026         0 1,323,529          
Ending balance, amount at Mar. 31, 2026 (40,249) 24,868 (65,249)   $ 0 $ 132          
Beginning balance, shares at Feb. 18, 2026         0 0          
Beginning balance, amount at Feb. 18, 2026 0 0 0   $ 0 $ 0          
Net income (loss) (11,199)     $ (7,093)              
Sale of Private Placement shares upon IPO, amount 2,750,000                    
Remeasurement of Class A ordinary shares subject to possible redemption to redemption value 4,000,719     4,000,719              
Ending balance, shares at Jun. 30, 2026         275,000 1,323,529 62,312,500 62,312,500     32,500,000
Ending balance, amount at Jun. 30, 2026 (1,236,918) 0 (1,237,078)   $ 28 $ 132 $ (13,538,000) $ 0 15,976,000 (29,514,000) $ 31,890,000
Beginning balance, shares at Mar. 31, 2026         0 1,323,529          
Beginning balance, amount at Mar. 31, 2026 (40,249) 24,868 (65,249)   $ 0 $ 132          
Net income (loss) 54,050   54,050 $ 37,841              
Sale of Private Placement shares upon IPO, shares         275,000 0          
Sale of Private Placement shares upon IPO, amount 2,750,000 2,749,972 0   $ 28 $ 0          
Remeasurement of Class A ordinary shares subject to possible redemption to redemption value (4,000,719) (2,774,840) (1,225,879)                
Ending balance, shares at Jun. 30, 2026         275,000 1,323,529 62,312,500 62,312,500     32,500,000
Ending balance, amount at Jun. 30, 2026 $ (1,236,918) $ 0 $ (1,237,078)   $ 28 $ 132 $ (13,538,000) $ 0 $ 15,976,000 $ (29,514,000) $ 31,890,000